



NFO Alert: From objective to risk, all you need to know about WhiteOak Capital Pharma and Healthcare Fund
WhiteOak Capital Mutual Fund announced the launch of the WhiteOak Capital Pharma and Healthcare Fund, an open-ended equity scheme investing in the pharma and healthcare sector. The scheme opened for public subscription on January 16, 2024, and will close on January 30, 2024.
The scheme re-opens for continuous sale and repurchase within five business days from the date of allotment. This is an open-ended equity scheme investing in the pharma and healthcare sector.
This product is suitable for investors seeking The investment objective of the scheme is to provide long-term capital appreciation by investing predominantly in equity and equity-related securities of pharma and healthcare companies. There is no assurance that the investment objective of the scheme will be realised.
Investors can invest under the scheme with a minimum investment of ₹500 per plan/option and in multiples of Re 1. There is no upper limit for investment.
Under normal circumstances, the asset allocation of the scheme will be as follows:Indicative allocations (% of total assets)MinimumMaximumEquity and equity-related instruments of pharma and healthcare companies80%100%Very HighEquity and equity-related instruments of companies other than the above0%20%Very HighUnits of REITs and InvITs0%10%Medium to HighDebt securities and money market instruments0%20%Low to Medium To date, many asset management companies (AMCs) have launched such healthcare funds. These include:Mutual Fund HouseName of the Fund5-year returns (in %)DSP Mutual FundDSP Healthcare Fund26.30SBI Mutual Fund SBI Healthcare Opportunities Fund22.33UTI Mutual FundUTI Healthcare Fund21.20Aditya Birla Sun Life Mutual FundAditya Birla Sun Life Pharma & Healthcare Fund-ITI Mutual FundITI Pharma &
. Read on livemint.com